维普中文期刊产品整合服务
2篇 您的检索式:作者名="Martin R Weiser"
    题名 作者 年代 出处 被引量
1Treatment of locally advanced rectal cancer:Controversies and questions显示文摘Rectal cancers extending through the rectal wall, or involving locoregional lymph nodes (T3/4 or N1/2), have been more difficult to cure. The confines of the bony pelvis and the necessity of preserving the autonomic nerves makes surgical extirpation challenging, which accounts for the high rates of local and distant relapse in this setting. Combined multimodality treatment for rectal cancer stage Ⅱ and Ⅲ was recommended from National Institute of Health consensus. Neoadjuvant chemoradiation using fluoropyrimidine-based regimen prior to surgical resection has emerged as the standard of care in the United States. Optimal time of surgery after neoadjuvant treatment remained unclear and prospective randomized controlled trial is ongoing. Traditionally, 6-8 wk waiting period was commonly used. The accuracy of studies attempting to determine tumor complete response remains problematic. Currently, surgery remains the standard of care for rectal cancer patients following neoadjuvant chemoradiation, where-as observational management is still investigational. In this article, we outline trends and controversies associated with optimal pre-treatment staging, neoadjuvant therapies, surgery, and adjuvant therapy.Atthaphorn Trakarnsanga Suthinee Ithimakin Martin R Weiser 2012World Journal of Gastroenterology2012,18,39:5
2Immunoblot analysis of c-Met expression in human colorectal cancer: Overexpression is associated with advanced stage cancer显示文摘Zhaoshi Zeng Martin R Weiser Matt D’Alessio Andrew Grace Jinru Shia Philip B. Paty 2004Clinical & Experimental Metastasis2004,,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费